CDKN2A and malignant colon neoplasm: The evidence is particularly strong in the case of CDNK2A (p16/ARF) where the presence of a mutation in the first exon in a colon cancer cell line facilitated the direct demonstration that hypermethylation occurs only on the wild-type allele [36].